RxDoctor Payments Data

Portia Smallbone, MD

Hematology · Houston, TXNPI 1093415796

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,290 of the $2,559 with a category attached, or 89.5%. 15 manufacturers reported payments, led by Astellas Pharma US Inc at 28.1% of the total. 2025 is the largest year on record at $1,967, 5.3 times the $373 reported in 2023. That places this record below the midpoint for hematology clinicians in TX, where the typical reported total is $822.

$2,559in general payments, 2019–2025

Across 39 payments — averaging $65.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$720
  • Jazz Pharmaceuticals Inc.$503
  • Incyte Corporation$281
  • Sanofi$157
  • Sanofi-aventis U.S. LLC$135
  • AbbVie$125
  • plus $638 from 9 others

What the payments were for

  • Food & beverage$2,29089%
  • Education$26911%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,559 in reported general payments places this provider in the 50th percentile of 97 hematology providers in Texas.

See all hematology providers in Texas

Medicare billing

Part B allowed, 2024
$16,276
Medicare patients
26
Services billed
134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →